
    
      6 months therapy with blinded Kaletra and Truvada vs. 6 months therapy with blinded placebo
      followed by 6 months open label therapy with Kaletra and Truvada

      18 month extension study with open label Kaletra and Truvada in patients completing 6 months
      of therapy with Kaletra and Truvada with biochemical endpoint
    
  